Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agave BioSystems was a biotechnology company specializing in the development of microfluidic systems and biosensors for point-of-care diagnostics and biodefense applications. The company focused on integrating micro-electromechanical systems (MEMS) with biological components to create highly sensitive detection platforms for pathogens and chemical agents. Their core technology involved automated microfluidic circuits capable of performing complex sample preparation and analysis in a portable format. Much of their research and development was supported by Small Business Innovation Research (SBIR) grants from agencies such as the DoD, NIH, and NASA. The company aimed to miniaturize laboratory processes for environmental monitoring and clinical use but is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agave BioSystems.